0001209191-19-039702.txt : 20190701 0001209191-19-039702.hdr.sgml : 20190701 20190701161447 ACCESSION NUMBER: 0001209191-19-039702 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20190627 FILED AS OF DATE: 20190701 DATE AS OF CHANGE: 20190701 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Kelly Jeffery W. CENTRAL INDEX KEY: 0001663552 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37695 FILM NUMBER: 19933361 MAIL ADDRESS: STREET 1: 200 TECHNOLOGY SQUARE STREET 2: 4TH FLOOR CITY: CAMBRIDGE STATE: MA ZIP: 02139 FORMER NAME: FORMER CONFORMED NAME: Kelly Jeffrey W. DATE OF NAME CHANGE: 20160113 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: PROTEOSTASIS THERAPEUTICS, INC. CENTRAL INDEX KEY: 0001445283 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE BUSINESS ADDRESS: STREET 1: 80 GUEST STREET STREET 2: 5TH FLOOR CITY: BOSTON STATE: MA ZIP: 02135 BUSINESS PHONE: 617-225-0096 MAIL ADDRESS: STREET 1: 80 GUEST STREET STREET 2: 5TH FLOOR CITY: BOSTON STATE: MA ZIP: 02135 FORMER COMPANY: FORMER CONFORMED NAME: PROTEOSTASIS THERAPEUTICS INC DATE OF NAME CHANGE: 20080916 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2019-06-27 0 0001445283 PROTEOSTASIS THERAPEUTICS, INC. PTI 0001663552 Kelly Jeffery W. C/O PROTEOSTASIS THERAPEUTICS, INC. 80 GUEST STREET, 5TH FLOOR BOSTON MA 02135 1 0 0 0 Stock Option (Right to Buy) 0.94 2019-06-27 4 A 0 15300 0.00 A 2029-06-27 Common Stock 15300 15300 D These securities shall vest and become exercisable in equal quarterly installments starting on June 27, 2019 until the option is fully vested and exercisable on June 27, 2020, subject to continued service. /s/ Janet L. Smart, Attorney-in-Fact 2019-07-01